JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellegrino, T.
Right arrow Articles by Cuocolo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellegrino, T.
Right arrow Articles by Cuocolo, A.
Journal of Nuclear Medicine Vol. 46 No. 12 1997-2002
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Relationship Between Brachial Artery Flow–Mediated Dilation and Coronary Flow Reserve in Patients with Peripheral Artery Disease

Teresa Pellegrino, MD1, Giovanni Storto, MD1,2, Pasquale Perrone Filardi, MD, PhD3, Anna Rita Sorrentino, MD, PhD1, Antonio Silvestro, MD3, Mario Petretta, MD3, Gregorio Brevetti, MD3, Massimo Chiariello, MD3, Marco Salvatore, MD1,2 and Alberto Cuocolo, MD1,2

1 Department of Biomorphological and Functional Sciences, University Federico II, Napoli, Italy
2 Institute of Biostructure and Bioimages, National Council of Research, Napoli, Italy
3 Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University Federico II, Napoli, Italy

The aim of this study was to assess the relationship between brachial artery flow–mediated dilation (FMD) and coronary flow reserve (CFR) in patients with peripheral artery disease (PAD). Methods: Thirty patients who had PAD, who showed no cardiac symptoms, and who had normal stress SPECT cardiac imaging results and 28 control subjects underwent brachial artery FMD assessment by ultrasound and dipyridamole 99mTc-sestamibi imaging. Myocardial blood flow (MBF) was estimated by measuring first-transit counts in the pulmonary artery and myocardial counts from SPECT images. Estimated CFR was expressed as the ratio of MBF at stress to MBF at rest. Results: Patients with PAD were separated into 2 groups according to the median value of overall FMD (6.85%): group 1 (n = 15) with FMD above the median (mean ± SD, 8.78% ± 1.3%) and group 2 (n = 15) with FMD below the median (mean ± SD, 5.14% ± 0.94%). FMD was significantly higher in control subjects (11.4% ± 3.4%) than in both groups of PAD patients (P < 0.001 for both). In control subjects, estimated CFR was 2.2 ± 0.4—significantly higher than CFR in both groups of PAD patients (P < 0.001 for both). In addition, in PAD patients of group 1, estimated CFR was 1.5 ± 0.4—higher than CFR in group 2 (1.0 ± 0.4) (P < 0.01). When all PAD patients were considered, a significant correlation between FMD and estimated CFR was observed (r = 0.56, P < 0.005). Conclusion: Estimated CFR is significantly lower in patients with PAD than in control subjects, and CFR impairment correlates with the degree of peripheral endothelial dysfunction.

Key Words: peripheral artery disease • flow-mediated dilation • coronary flow reserve


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  



This article has been cited by other articles:


Home page
Vasc MedHome page
S. Haugen, I. P. Casserly, J. G. Regensteiner, and W. R. Hiatt
Risk assessment in the patient with established peripheral arterial disease
Vascular Medicine, November 1, 2007; 12(4): 343 - 350.
[Abstract] [PDF]


Home page
Vasc MedHome page
T. W. Rooke
Controversies in vascular screening art versus science
Vascular Medicine, August 1, 2007; 12(3): 235 - 242.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.